4.8 Article

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation

期刊

FRONTIERS IN IMMUNOLOGY
卷 14, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2023.1192440

关键词

immune profile; biomarker; acute rejection; kidney transplantation; hierarchical clustering analysis

向作者/读者索取更多资源

Unsupervised hierarchical clustering analysis was performed on pre-transplant immunological phenotype in 1113 renal transplant recipients, identifying three immune profiles correlated with clinical phenotypes. The memory immune cluster was associated with older age and diabetes, while the activated immune cluster was associated with younger age and previous exposure to CMV. Both were associated with an increased risk of acute rejection.
BackgroundAcute rejection persists as a frequent complication after kidney transplantation. Defining an at-risk immune profile would allow better preventive approaches. MethodsWe performed unsupervised hierarchical clustering analysis on pre-transplant immunological phenotype in 1113 renal transplant recipients from the ORLY-EST cohort. ResultsWe identified three immune profiles correlated with clinical phenotypes. A memory immune cluster was defined by memory CD4(+)T cell expansion and decreased naive CD4(+)T cell. An activated immune cluster was characterized by an increase in CD8(+)T cells and a decreased CD4/CD8 ratio. A naive immune cluster was mainly defined by increased naive CD4(+)T cells. Patients from the memory immune profile tend to be older and to have diabetes whereas those from the activated immune profile were younger and more likely to have pre-transplant exposure to CMV. Patients from the activated immune profile were more prone to experience acute rejection than those from other clusters [(HR=1.69, 95%IC[1.05-2.70], p=0.030) and (HR=1.85; 95%IC[1.16-3.00], p=0.011). In the activated immune profile, those without previous exposure to CMV (24%) were at very high risk of acute rejection (27 vs 16%, HR=1.85; 95%IC[1.04-3.33], p=0.039). ConclusionImmune profile determination based on principal component analysis defines clinically different sub-groups and discriminate a population at high-risk of acute rejection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据